News
The patent trap? Open science advocates want CRISPR technology to be free
Published: 13 December 2016
"The overall guiding principle is not open for the sake of 'open,' but whatever is necessary to find new treatments more rapidly for diseases."聽Dr. Guy聽Rouleau, director of the聽Montreal Neurological Institute at聽McGill聽University.聽
Read more: